Significance of Factor V,Prothrombin,MTHFR,and PAI-1 Genotypes in Childhood Cerebral Thrombosis

Abstract

The aim of this study was to evaluate the significance of factor V (FV) G1691A, prothrombin G20210A, methylenetetrahydrofolate reductase (MTHFR) C677T, and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotypes in development of childhood cerebral thrombosis (CT). A total of 113 Turkish children with CT were studied and compared with the control group. The carrier frequency of the factor V G1691A mutation was found to be significantly higher in the patient group (17.7%) than controls (7.4%). The presence of this genotype was associated with a 2.7-fold increased risk of developing CT (95% confidence interval [CI], 1.0—7.0). The prevalence of prothrombin G20210A mutation in 110 patients (4.5%) was insignificantly higher than controls (2.3%) (odds ratio, 2.0; 95% CI, 0.4—10.7). A statistically significant increase in the frequency of homozygous MTHFR C677T genotype was observed in 62 patients (11.3%) compared to controls (4.3%), and this genotype was associated with 2.8-fold increased CT risk (95% CI, 1.0—8.0). The incidence of PAI-1 4G/4G genotype in 65 patients (21.5%) was slightly lower than that of controls (26.0%), but the differences did not reach statistical significance (odds ratio, 0.8; 95% CI, 0.4—1.5). The results of this study suggested that factor V G1691A and MTHFR C677T genotypes may be associated with an increased risk of developing CT in Turkish children.

Keywords

Cerebral thrombosis Childhood Genetic risk factors.

References

Riela AR , Roach ES Etiology of stroke in children. J Child Neurol 1993;8:201.

Akar N. , Akar E. , Deda G. Coexistence of two prothrombotic mutations, factor V 1691 G-A and prothrombin gene 20210 G-A, and the risk of cerebral infarct in pediatric patients. Pediatr Hematol Oncol 1999;16:565.

Kenet G. , Sadetzki S. , Murad H. , et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283.

Nowak-Gottl U. , Strater R. , Heinecke A. , et al, for Childhood Stroke Study Group. Lipoprotein (a) and genetic polymorphism of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678.

Zenz W. , Bodó Z. , Plotho J. , et al. Factor V Leiden and prothrombin gene G20210A variant in children with ischemic stroke. Thromb Haemost 1998;80:763.

Bonduel M. , Sciuccati G. , Hepner M. , et al. Factor V Leiden and prothrombin G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003; 73:81.

Ganesan V. , Prengler M. , McShane MA , et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003;53:167.

McColl MD , Chalmers EA , Thomas A. , et al. Factor V Leiden, prothrombin 20210 GøA and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999;81: 690.

Akar N. , Akar E. , Deda G. , et al. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol 1999;14:749.

10.

Prengler M. , Sturt N. , Krywawych S. , et al. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: A potential risk factor for hyperhomocysteinemia, CVD, and stroke in childhood. Dev Med Child Neurol 2001;43:220.

11.

Cardo E. , Monros E. , Colome C. , et al. Children with stroke: Polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol 2000;15:295.

12.

Akar N. , Akar E. , Ylmaz E. , Deda G. Plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation. J Child Neurol 2001;16:294.

13.

Nowak-Gottl U. , Strater R. , Kosch A. , et al. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group. Eur J Haematol 2001;66:57.

14.

Vielhaber H. , Ehrenforth S. , Koch HG , et al. Cerebral venous sinus thrombosis in infancy and childhood: Role of genetic and acquired risk factors of thrombophilia . Eur J Pediatr 1998;157:555.

15.

DeVeber G. , Andrew M. , Adams C. , et al, for the Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417.

16.

Gurgey A. , Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997;39: 313.

17.

Gurgey A. , Hicsonmez G. , Parlak H. , et al. The prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol 1998;59:179.

18.

Balta G. , Yuksek N. , Ozyurek E. , et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, CYPA1 genotypes in childhood leukemia. Am J Hematol 2003; 73:154.

19.

Balta G. , Altay C. , Gurgey A. PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs. Am J Hematol 2002; 71:89.

20.

Bertina RM , Koeleman Bpc , Koster T. , et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64.

21.

Poort SR , Rosendaal FR , Reistma PH , Bertina RM A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698.

22.

Frosst P. , Blom HJ , Milos R. , et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111.

23.

Doggen Cjm , Bertina RM , Manger Cats V. , et al. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 1999;82:115.

24.

deVeber G. , Monagle P. , Chan A. , et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539.

25.

Lynch JK , Nelson KB , Curry CJ , Grether JK Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 2001;16:735.

26.

Gurgey A. Clinical manifestations in thrombotic children with factor V Leiden mutation . Pediatr Hematol Oncol 1999;16:233.